Market Announcement - Appointment of New CEO at TMLEP

Market Announcement

Appointment of New CEO at TMLEP.

TMLEP is delighted to announce the appointment of Martin Dew as Chief Executive Officer, succeeding Oliver Maughan, who is stepping down after more than a decade of dedicated leadership marked by consistent year-on-year growth and strategic innovation.

Under Oliver’s guidance, TMLEP has transformed the investigation of clinical incidents, significantly enhancing how insurers, legal teams, and healthcare providers resolve liabilities with greater speed, accuracy, and efficiency. Oliver’s visionary leadership has placed TMLEP firmly on the path toward becoming a hyper-specialist healthcare consultancy, extending its expertise beyond clinical liabilities to proactive, reactive, and preventative clinical risk management.

Martin’s appointment marks the next chapter in this journey, specifically aimed at accelerating and executing this strategic vision. His leadership will reinforce TMLEP’s commitment to building resilience within healthcare providers, proactively driving improvements in patient safety and clinical outcomes, and positioning the company as a global leader in specialist healthcare consultancy and risk management services.

Martin joins TMLEP from RLDatix & Allocate Software, global leaders in healthcare technology and workforce solutions dedicated to safer patient care—a mission closely aligned with TMLEP’s values and future ambitions. Throughout his career, including his previous role at OneAdvanced, Martin has championed innovative technology solutions to enhance healthcare delivery and workforce support, making him ideally suited to lead TMLEP forward.

Martin Dew commented: “It’s a privilege to join TMLEP at such a pivotal time. The company is uniquely positioned to extend its consultancy and real-time response services globally, helping healthcare providers proactively manage clinical risk, adopt cutting-edge technologies, and improve patient outcomes. I’m excited to lead this next phase of growth alongside the exceptional team at TMLEP.”

Oliver Maughan added:

“Since TMLEP’s inception, I’ve had the privilege of strategically shaping and driving its growth from a start-up into a recognised market leader in assessing clinical liabilities. Together with outstanding colleagues and key partners, we’ve built an exceptional team and fostered a culture of innovation, creating a robust platform that’s now perfectly positioned for rapid global expansion into healthcare consultancy and clinical risk management. Martin has exactly the right expertise, ambition, and energy to successfully lead TMLEP through its next phase, scaling services globally to drive resilience within healthcare providers—ensuring clinical risks are managed effectively, and wherever adverse incidents occur, standards of care and patient safety are continuously improved.”

TMLEP warmly welcomes Martin Dew and looks forward to continued innovation, growth, and global impact under his leadership.